Columbia, SC, United States of America

Metin Cetin

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Metin Cetin: Innovator in Cancer Treatment

Introduction

Metin Cetin is a prominent inventor based in Columbia, SC (US). He has made significant contributions to the field of medical research, particularly in the development of novel compounds for cancer treatment.

Latest Patents

Cetin holds a patent for "Inhibitors of lysyl oxidases." This patent describes innovative compounds that effectively block the activity of LOX family members. These compounds exhibit good IC50 values, show no cellular toxicity below 10 µM, and induce sensitization of cells to doxorubicin. They also demonstrate strong activity in recombinant LOX/LOXL2 assays and possess a drug-like chemical structure without a PAINS flag. The methods of treatment using these compounds target cancer, organ fibrosis, neurodegenerative, and cardiovascular diseases.

Career Highlights

Metin Cetin is affiliated with the University of South Carolina, where he continues to advance his research and contribute to the scientific community. His work has garnered attention for its potential impact on various diseases.

Collaborations

Cetin collaborates with notable colleagues, including Ozgur Sahin and Campbell McInnes, enhancing the breadth and depth of his research efforts.

Conclusion

Metin Cetin's innovative work in developing inhibitors of lysyl oxidases showcases his commitment to advancing medical science and improving treatment options for serious health conditions. His contributions are paving the way for future breakthroughs in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…